198HO02197 KITAMI *PP

Print/PDF
Registration Name WIL KITAMI-ET
Registration Number HODEU000540355289
Primary NAAB Code 198HO02197
Secondary Code(s) 598HO02197
Status Inactive
Controller Name INTERMIZOO S.p.A. (198)
Date of Birth 2/22/2019
aAa 153264
DMS -
GFI 11.7%
Genetic Codes * RC PP TL TC TD TV TY TE
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HHP-A, HHR-C
Sire WILDER HOTSPOT P-ET
MGS MR SALVATORE RC-ET
Beta Casein A1A2
Kappa Casein BE
Beta Lactoglobulin AA
INDEXES
NM$ 97, 85% R CM$ 109
NM Percentile 20% FM$ 68
GTPI 2685 GM$ 79
PRODUCTION TRAITS
3691 Dtrs 1116 herds 2 % US 94% R
Milk 396 Fat, % 4 , -0.05%
SCS 3.04, 92% R Protein, % 21 , +0.03%
Feed Saved -158 , 54% R Milking Speed 7.08 , 65% R
Health & Fertility
Productive Life 1.1      92% R Mastitis 1.1      75% R
Heifer Livability -0.3       54% R Metritis 2.2      70% R
Livability 0.4      75% R D. Abom 0.2      73% R
DPR 0.7      91% R Ketosis 0.9      69% R
FSC -1.1      86% R R. Placenta 0.6      71% R
HCR -1.6      89% R Milk Fever -0.1      63% R
CCR 0.1      91% R
SCR -        -
DIA 0.8      41% R
RSP -1.0      49% R
Calving Traits
Sire CE 1.3      89% R 8069 Obs
Daughter CE 1.4      78% R 43 Obs, 3040 Dtrs
Sire SB 3.3      73% R 10754 Obs
Daughter SB 4.5      80% R 12 Obs, Dtrs
Gestation Length -1.7      96% R 98 Obs, 915 Dtrs
Early First Calving -2.0      81% R 13 Obs, 52 Dtrs

CDCB August 2026; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 08/2026
1232 Dtrs 495 herds 90% R
PTA Type 0.82 UDC 0.17
HCC 1.50 BWC 0.80
FLC 0.75
Linear Traits
Stature 0.68
Tall
Strength 0.85
Strong
Body Depth 0.70
Deep
Dairy Form -0.03
Closed
Rump Angle -0.34
Flat
Thurl Width -0.24
Flat
Rear Legs-Side View -0.24
Narrow
Rear Legs-Rear View 1.03
Straight
Foot Angle 0.60
Steep
Feet & Legs Score 0.81
High
F.U. Attachment -0.32
Straight
Rear Udder Height -0.16
Low
Rear Udder Width 0.22
Wide
Udder Cleft -0.33
Weak
Udder Depth 1.03
Straight
Front Teat Placement -0.48
Wide
Rear Teat Placement -0.75
Wide
Teat Length 2.14
Long
-2
0
2

CDCB August 2026; Base of Evaluation: HO